Kesselheim AS - Search Results

1

Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials.

Dal-Ré R, Kesselheim AS, Bourgeois FT. Dal-Ré R, et al. Among authors: kesselheim as. JAMA. 2020 May 19;323(19):1903-1904. doi: 10.1001/jama.2020.1631. JAMA. 2020. PMID: 32324205 No abstract available.

2

University-based science and biotechnology products: defining the boundaries of intellectual property.

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2005 Feb 16;293(7):850-4. doi: 10.1001/jama.293.7.850. JAMA. 2005. PMID: 15713775

3

The role of litigation in defining drug risks.

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2007 Jan 17;297(3):308-11. doi: 10.1001/jama.297.3.308. JAMA. 2007. PMID: 17227983 No abstract available.

4

Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.

Kesselheim AS, Myers JA, Avorn J. Kesselheim AS, et al. JAMA. 2011 Jun 8;305(22):2320-6. doi: 10.1001/jama.2011.769. JAMA. 2011. PMID: 21642684

5

Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.

Greene JA, Choudhry NK, Kesselheim AS, Brennan TA, Shrank W. Greene JA, et al. Among authors: kesselheim as. JAMA. 2012 Sep 12;308(10):973-5. doi: 10.1001/2012.jama.10647. JAMA. 2012. PMID: 22968881 No abstract available.

6

FDA regulation of off-label drug promotion under attack.

Kesselheim AS, Mello MM, Avorn J. Kesselheim AS, et al. JAMA. 2013 Feb 6;309(5):445-6. doi: 10.1001/jama.2012.207972. JAMA. 2013. PMID: 23385267 No abstract available.

7

Who is now responsible for discovering and warning about adverse effects of generic drugs?

Kesselheim AS, Green MD, Avorn J. Kesselheim AS, et al. JAMA. 2013 Sep 11;310(10):1023-4. doi: 10.1001/jama.2013.228349. JAMA. 2013. PMID: 23922000 No abstract available.

8

FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.

Rome BN, Kramer DB, Kesselheim AS. Rome BN, et al. Among authors: kesselheim as. JAMA. 2014 Jan 22-29;311(4):385-91. doi: 10.1001/jama.2013.284986. JAMA. 2014. PMID: 24449317 Free PMC article.

9

What is the public's right to access medical discoveries based on federally funded research?

Treasure CL, Avorn J, Kesselheim AS. Treasure CL, et al. Among authors: kesselheim as. JAMA. 2014 Mar 5;311(9):907-8. doi: 10.1001/jama.2014.404. JAMA. 2014. PMID: 24595771 No abstract available.

10

Underrepresentation of older adults in cancer trials.

Luo J, Kesselheim AS. Luo J, et al. Among authors: kesselheim as. JAMA. 2014 Mar 5;311(9):965-6. doi: 10.1001/jama.2013.286454. JAMA. 2014. PMID: 24595789 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters